Your browser doesn't support javascript.
loading
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Kuppermann, Baruch D; Patel, Sunil S; Boyer, David S; Augustin, Albert J; Freeman, William R; Kerr, Kevin J; Guo, Qiang; Schneider, Susan; López, Francisco J.
Afiliação
  • Kuppermann BD; Gavin Herbert Eye Institute, University of California Irvine, Irvine, California.
  • Patel SS; West Texas Retina, Abilene, Texas.
  • Boyer DS; Retina-Vitreous Associates Medical Group, Los Angeles, California.
  • Augustin AJ; Department of Ophthalmology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Freeman WR; Jacobs Retina Center, University of California San Diego, San Diego, California; and.
  • Kerr KJ; Allergan plc, Irvine, California.
  • Guo Q; Allergan plc, Irvine, California.
  • Schneider S; Allergan plc, Irvine, California.
  • López FJ; Allergan plc, Irvine, California.
Retina ; 41(1): 144-155, 2021 Jan 01.
Article em En | MEDLINE | ID: mdl-32134802
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acuidade Visual / Atrofia Geográfica / Tartarato de Brimonidina / Degeneração Macular Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acuidade Visual / Atrofia Geográfica / Tartarato de Brimonidina / Degeneração Macular Idioma: En Ano de publicação: 2021 Tipo de documento: Article